Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia : t(8;21) and inv(16) represent different clinical outcomes

Author

KUWATSUKA, Yachiyo¹ ; MIYAMURA, Koichi¹ ; ATSUTA, Yoshiko² ; YOSHIDA, Takashi¹⁰ ; SAKAMAKI, Hisashi¹¹ ; KODERA, Yoshihisa¹ ; SUZUKI, Ritsuro² ; KASAI, Masaharu³ ; MARUTA, Atsuo⁴ ; OGAWA, Hiroyasu⁵ ; TANOSAKI, Ryuji⁶ ; TAKAHASHI, Satoshi⁷ ; KODA, Kyuhei⁸ ; YAGO, Kazuhiro⁹
[1] Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
[2] Department of HSCT Data Management, Nagoya University School of Medicine, Nagoya, Japan
[3] Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
[4] Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
[5] Department of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
[6] Stem Cell Transplantation Unit, National Cancer Center Hospital, Tokyo, Japan
[7] Department of Hematology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
[8] Department of Hematology, Asahikawa Red Cross Hospital, Asahikawa, Japan
[9] Department of Hematology, Shizuoka General Hospital, Shizuoka, Japan
[10] Hematology Department, Toyama Prefectural Hospital, Toyama, Japan
[11] Department of Hematology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan

Source

Blood. 2009, Vol 113, Num 9, pp 2096-2103, 8 p ; ref : 37 ref

ISSN

0006-4971

Scientific domain

Medical oncology; Hematology

Publisher

Americain Society of Hematology, Washington, DC

Publication country

United States

Document type

Article

Language

English

Keyword (fr)

Cellule hématopoïétique Cellule souche Chromosome C8 anormal Chromosome E16 anormal Chromosome G21 anormal Cytogénétique Greffe Homme Inversion chromosomique Leucémie aiguë myéloblastique Pronostic Traitement Translocation chromosomique Facteur de transcription CBF Aberration chromosomique Cancer Chromosome anormal Hémopathie maligne Syndrome myéloprolifératif

Keyword (en)

Hematopoietic cell Stem cell Abnormal chromosome C8 Abnormal chromosome E16 Abnormal chromosome G21 Cytogenetics Graft Human Chromosome inversion Acute myelogenous leukemia Prognosis Treatment Chromosome translocation Transcription factor CBF Chromosomal aberration Cancer Abnormal chromosome Malignant hemopathy Myeloproliferative syndrome

Keyword (es)

Célula hematopoyética Célula primitiva Cromosoma C8 anormal Cromosoma E16 anormal Cromosoma G21 anormal Citogenética Injerto Hombre Inversión cromosómica Leucemia aguda mieloblástica Pronóstico Tratamiento Translocación cromosómica Factor de transcripción CBF Aberración cromosómica Cáncer Cromosoma anormal Hemopatía maligna Mieloproliferativo síndrome

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27D Transfusions. Complications. Transfusion reactions. Cell and gene therapy / 002B27D02 Bone marrow, stem cells transplantation. Graft versus host reaction

Discipline

Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Blood diseases

Origin

Inist-CNRS

Database

PASCAL

INIST identifier

21205385

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS